Published in Pharmacol Biochem Behav on December 01, 1982
Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 3.97
A potent and selective endogenous agonist for the mu-opiate receptor. Nature (1997) 3.87
Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology (1998) 2.89
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Hypertriiodothyroninaemia as a premonitory manifestation of thyrotoxicosis. Lancet (1971) 2.58
Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science (1971) 2.43
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol (1993) 2.08
Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation (1996) 1.94
Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol (2001) 1.80
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides (1998) 1.58
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
Echocardiographic diagnosis of left atrial myxoma. Am J Cardiol (1974) 1.56
Activity and specificity of synthetic thyrotropin-releasing hormone in man. Biochem Biophys Res Commun (1970) 1.47
Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. J Am Coll Cardiol (1993) 1.45
Isolation and structure of hypothalamic MSH release-inhibition hormone. Biochem Biophys Res Commun (1971) 1.43
Hypothalamic regulatory hormones. Science (1973) 1.41
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med (1971) 1.40
Death associated with ventricular arrhythmia and thioridazine hydrochloride. JAMA (1968) 1.40
Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol (1994) 1.38
Hypothalamic neurohormones regulating anterior pituitary function. Recent Prog Horm Res (1968) 1.36
Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol (1999) 1.36
Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies. Fertil Steril (1971) 1.35
Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett (1994) 1.32
The hypothalamus and reproduction. Am J Obstet Gynecol (1972) 1.29
Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha. Am J Physiol (1996) 1.26
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). Life Sci I (1971) 1.23
Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides (1997) 1.22
Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier. Life Sci (1994) 1.21
Clinical experience with hypothalamic releasing hormones. 1. Thyrotropin-releasing hormone. Recent Prog Horm Res (1972) 1.21
Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides (1997) 1.20
Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci (1991) 1.19
The role of viruses in the production of heart disease. Am J Cardiol (1972) 1.18
Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. J Cell Sci (1998) 1.18
Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol (1999) 1.15
Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull (1989) 1.15
Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med (1987) 1.13
Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet (1972) 1.13
Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones. Recent Prog Horm Res (1972) 1.13
Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol (1990) 1.11
Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Neuroendocrinology (2000) 1.11
Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol (1997) 1.10
Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull (1985) 1.10
The cardiomyopathy of hypoparathyroidism. Another reversible form of heart muscle disease. Chest (1981) 1.10
Mahogany, blood-brain barrier, and fat mass surge in AVY mice. Int J Obes (Lond) (2007) 1.09
Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp Neurol (1997) 1.09
Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides (1997) 1.08
The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations. Life Sci (1997) 1.08
Alcoholic cardiomyopathy. Concept of the disease and its treatment. Am J Med (1971) 1.08
Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev (1997) 1.07
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides (1998) 1.06
An analog of enkephalin having prolonged opiate-like effects in vivo. Science (1977) 1.06
Echocardiographic diagnosis of vegetative aortic bacterial endocarditis. Am J Cardiol (1974) 1.06
Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers. Brain (1997) 1.06
Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion. Exp Neurol (2001) 1.05
Ischemic cardiomyopathy. Am Heart J (1970) 1.05
Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology (1998) 1.05
Endogenous opiates: 1999. Peptides (2000) 1.05
Proceedings: Effect of somatostatin on motilin levels and gastric emptying. Gut (1975) 1.05
Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther (1993) 1.04
Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier. Neurosci Biobehav Rev (1989) 1.04
Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. Arch Gen Psychiatry (1974) 1.03
Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci (2001) 1.03
Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine. Peptides (1994) 1.02
Glucagon control of fasting glucose in man. Lancet (1974) 1.02
Effect of synthetic hypothalamic gonadotropin-releasing hormone (FSH-LH-RH) in anovulatory sterility. Fertil Steril (1974) 1.01
Permeability of the blood-brain barrier to amylin. Life Sci (1995) 1.01
Quantifying carrier-mediated transport of peptides from the brain to the blood. Methods Enzymol (1989) 1.01
Release of LH and FSH after administration of synthetic LH-releasing hormone. J Clin Endocrinol Metab (1972) 1.00
HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sci (1997) 0.99
Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am J Physiol (1986) 0.99
Stimulation of LH release in men and women by LH-releasing hormone purified from porcine hypothalami. J Clin Endocrinol Metab (1969) 0.99
Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation (1996) 0.99
Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology (1996) 0.98
Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury. J Neurosci (1999) 0.98
Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides (1997) 0.97
Responses to thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men. J Clin Endocrinol Metab (1973) 0.97
Peptides and thermoregulation. Neurosci Biobehav Rev (1980) 0.97
Permeability of the blood-brain barrier to neurotrophins. Brain Res (1998) 0.96
Purification of a bovine hypothalamic factor which elevates pituitary MSH levels in rats. Endocrinology (1966) 0.96
Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density. Ann N Y Acad Sci (1999) 0.96
Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF). Proc Soc Exp Biol Med (1972) 0.96
Comparison of long-acting analogues of luteinizing hormone releasing hormone in man. Clin Endocrinol (Oxf) (1979) 0.95
Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides (1997) 0.95
The neurotrophins and their receptors: structure, function, and neuropathology. Neurosci Biobehav Rev (1994) 0.94
Neuroendocrine influences on visual discrimination and reversal learning in the albino and hooded rat. Physiol Behav (1973) 0.94
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens (2007) 0.94
Effectf of synthetic luteinizing hormone-releasing hormone (LH-RH) in two brothers with hypogonadotropic hypogonadism and anosmia. J Clin Endocrinol Metab (1973) 0.94
Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA. Nitric Oxide (1998) 0.94
Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease. Can Med Assoc J (1972) 0.93
Isolation and structure of pro-methionine-enkephalin: Potential enkephalin precursor from porcine hypothalamus. Proc Natl Acad Sci U S A (1979) 0.93
MSH activity in pituitaries of rats treated with hypothalamic extracts. Gen Comp Endocrinol (1966) 0.93
Passage of leptin across the blood-testis barrier. Am J Physiol (1999) 0.93
Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci (1996) 0.92
Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides (1998) 0.92
Saturable entry of leukemia inhibitory factor from blood to the central nervous system. J Neuroimmunol (2000) 0.92
Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res (2000) 0.92